LogoLogo
  • Technology
  • Events
  • Company
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic

Regulatory Updates

Updates and notices relevant to regulatory compliance.

3 items

Regulatory update
January 14, 2026

Discontinuation of Tixel 1

View details
Regulatory update
January 14, 2026

510(k) Skin Rejuvenation Clearance

Novoxel announces that Tixel® has received 510(k) clearance for dermatological procedures requiring ablation and resurfacing of the skin.

View details
Regulatory update
January 3, 2026

510(k) Dry Eye Clearance

Novoxel announces U.S. FDA 510(k) clearance of Tixel i® for application of localized heat and pressure for patients with evaporative dry eye due to MGD.

View details
Logo

Discover Tixel® powered by TMA® technology. Revolutionary fractional skin resurfacing with maximum safety, minimal side effects. Quick, effective treatments for aesthetic and dry eye applications.

Support
  • Get Support
  • Request a Demo
Product
  • Aesthetics
  • Vision
Company
  • About the Company
  • Contact Us
  • Events
Resources
  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials
Legal
  • Intellectual Property
  • Counterfeit Devices Warning
Regulation
  • Quality Assurance
  • Regulatory Updates

Product

  • Aesthetics
  • Vision

Company

  • About the Company
  • Contact Us
  • Events

Resources

  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials

Support

  • Get Support
  • Request a Demo

Legal

  • Intellectual Property
  • Counterfeit Devices Warning

Regulation

  • Quality Assurance
  • Regulatory Updates

Newsletter

Stay updated with our latest Tixel news.

© 2026 Tixel®, Novoxel®, and TMA®. All rights reserved.

Privacy policyCookie preferences